HOME >> MEDICINE >> NEWS
Neurobiology of dread gives scientists clues about human decision making

ATLANTA -- In order to better understand how people make decisions when the outcomes are known to be unpleasant, a team of Emory neuroscientists led by Gregory Berns, MD, PhD, used functional magnetic resonance imaging (fMRI) to determine the areas of the brain that are activated when someone experiences dread. The study, which was supported by the National Institutes of Drug Abuse (NIDA), was published in the May 5, 2006 issue of the journal Science. The study was part of a research program in the growing field of neuroeconomics, an area in which neuroscience methods are being applied to economic questions.

"Most people don't like waiting for an unpleasant outcome, and want to get it over with as soon as possible," explains Dr. Berns, an associate professor in the Department of Psychiatry and Behavioral Sciences at Emory University School of Medicine. "The only explanation for this is that the dread of having something hanging over your head is worse than the thing that you are dreading. It is a commonplace experience, but standard economic models of decision-making don't deal with this issue. So, we decided to take a biological approach and see what happens in the brain that might cause people to make such rash decisions."

The study was conducted using an fMRI scanner to look at the brains of the study participants while delivering a series of low voltage shocks to the foot of each participant, with different levels of intensity and different time delays up to the shock. Each of the participants in the study was screened to determine their maximal pain threshold. While in the MRI scanner, participants underwent a series of 96 shocks. Before each shock, they were told how painful the shock would be (as a percent of their threshold) and how long they would have to wait for it. After the scanning procedure, they were then given the opportunity to choose between different intensity-delay combinations, the choice was always between more pain s
'"/>

Contact: Kathi Baker
kobaker@emory.edu
404-727-9371
Emory University Health Sciences Center
4-May-2006


Page: 1 2 3

Related medicine news :

1. Once-dreaded leprosy replaced by tuberculosis, say researchers
2. Dyson Foundation gives $5 Million for ophthalmology research at Weill Cornell Medical College
3. Thymus transplants gives hope to babies with fatal immune disease
4. Plasmonics book gives overview of technology that could revolutionize computing
5. Study of leukemia survivors gives hints for better care
6. New Inteleos features gives users the ability to tailor information
7. Breast cancer treatment procedure gives women more options
8. Woodruff Foundation gives major boost to Emory Universitys strategic plan
9. Core needle biopsy gives an accurate picture of gene expression in whole tumor
10. NICE gives backing for the use of advanced biological therapies to treat severe psoriasis
11. National trial gives unprecedented support for steroid withdrawal in kidney transplants

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/28/2017)... (PRWEB) , ... July 28, 2017 , ... Kevin Harrington, one of the original Sharks ... announce the launch of a new DRTV campaign with My Real Earth. , Most people ... our bodies is just as important as what we put in our bodies. After all, ...
(Date:7/28/2017)... ... July 28, 2017 , ... For over 20 years Sealy Baby has been ... babies. We take tremendous pride in using some of nature’s best materials while integrating ... and innovative crib mattresses and crib bedding for infants and ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... through an alliance of independent physicians, has launched a new educational series of ... Jersey’s new regulations governing the prescribing of pain medication. The first two episodes ...
(Date:7/27/2017)... ... July 27, 2017 , ... Patients with ... in a single office visit from Dr. Alejandro Kovacs. Dr. Kovacs is a ... East Texas patients, including Teeth-in-a-Day® dental implants in Longview, TX. ...
(Date:7/27/2017)... , ... July 27, 2017 , ... ... Verification to State Medicaid programs, Managed Care Organizations and Home Care Agencies, has ... The MEDsys platform, VinCENT, provides technology solutions to over 1,000 agencies and multiple ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... Lilly and Company (NYSE: LLY ) has entered ... patent litigation in the U.S. District Court for the Eastern ... ® (tadalafil) unit dose patent. This patent was previously ... the agreement, Cialis exclusivity is now expected to end at ... dose patent for Cialis is valid and infringed by companies ...
(Date:7/11/2017)...  The global market for liquid biopsy diagnostic and ... in 2016.  Although in early stages, the global market ... as a result of the gradual shift towards personalized ... of a significant number of new liquid biopsy tests ... biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... , July 11, 2017 Oramed Pharmaceuticals ... a clinical-stage pharmaceutical company focused on the development of ... Food and Drug Administration (FDA) has agreed to schedule ... completed Phase IIb trial of its oral insulin capsule ... Phase IIb trial met primary and secondary endpoints by ...
Breaking Medicine Technology:
Cached News: